Nature Medicine, Published online: 22 October 2026; doi:10.1038/s41591-026-04750-7
Author Correction: β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
Science News
Nature Medicine, Published online: 22 October 2026; doi:10.1038/s41591-026-04750-7
Author Correction: β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
